Rafarma Pharmaceuticals (RAFA) Commences Preparation of Audited Financials
May 12, 2014 09:15 ET
|
Rafarma Pharmaceuticals, Inc.
MOSCOW, May 12, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (Pink Sheets:RAFA) has commenced a formal audit to provide additional transparency in its public filings with a forward view to...
Rafarma (RAFA) Enters $50,000,000 Ceftriaxone Market and Signs Long-Term National and Regional Distribution Contracts
June 06, 2013 09:18 ET
|
Rafarma Pharmaceuticals, Inc.
SANDY, Utah, June 6, 2013 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (the "Company") (Pink Sheets:RAFA) announces commencement of production of the antibiotic Ceftriaxone.
Ceftriaxone treats...
Four EndoHeroes(TM) Honored for Contributions
March 27, 2013 07:00 ET
|
EndoChoice
ALPHARETTA, GA--(Marketwire - Mar 27, 2013) - In recognition of GI Nurses Day and the many GI professionals who dedicate themselves to patient care, EndoChoice, Inc. is honoring four GI...
EndoChoice Awarded GI Contract With the Premier Healthcare Alliance
January 22, 2013 11:15 ET
|
EndoChoice
ALPHARETTA, GA--(Marketwire - Jan 22, 2013) - EndoChoice, Inc. announced today that it has been awarded a group purchasing agreement with the Premier Healthcare Alliance for its gastrointestinal...
EndoChoice Recognized as One of Georgia's Top Job Creators
December 07, 2012 07:18 ET
|
EndoChoice
ALPHARETTA, GA--(Marketwire - Dec 7, 2012) - EndoChoice, Inc., a platform technology company focused on gastrointestinal (GI) endoscopy, is featured in the inaugural ranking of Inc. Magazine's...
Tranzyme Pharma Announces Third Quarter 2012 Financial Results
November 08, 2012 16:30 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class...
Tranzyme Pharma to Host Third Quarter 2012 Financial Results Conference Call on Friday, November 9, 2012
October 25, 2012 05:10 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will host a conference call on Friday, November 9, 2012 at 8:30 am ET to discuss...
Tranzyme Pharma to Present at BIO Investor Forum on October 10, 2012
October 03, 2012 13:30 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 3, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin K. Garg, Ph.D., President and CEO, will present at the 11th Annual BIO Investor...
Tranzyme Pharma Announces Exercise of Underwriters' Over-Allotment Option and Closing of $11.5 Million Registered Direct Offering of Common Stock
September 18, 2012 16:30 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 18, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that it has closed the previously announced underwritten registered direct offering of...
Tranzyme Pharma Raises $10 Million in Registered Direct Offering
September 13, 2012 05:10 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it has agreed to sell approximately 2.6 million shares of its common stock at a...